Detalhe da pesquisa
1.
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
Nature
; 586(7830): 578-582, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731258
2.
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Clin Exp Immunol
; 211(3): 280-287, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729167
3.
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
Nature
; 590(7844): E24, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469217
4.
Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria.
Infect Immun
; 88(2)2020 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740525
5.
The Threshold of Protection from Liver-Stage Malaria Relies on a Fine Balance between the Number of Infected Hepatocytes and Effector CD8+ T Cells Present in the Liver.
J Immunol
; 198(5): 2006-2016, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28087668
6.
Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.
J Immunol
; 2017 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28724579
7.
Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster.
Hum Vaccin Immunother
; 19(1): 2175558, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36785938
8.
Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model.
EBioMedicine
; 90: 104523, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36933409
9.
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines.
Sci Rep
; 12(1): 14464, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002507
10.
ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants.
Nat Commun
; 13(1): 4610, 2022 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941149
11.
Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster model.
Res Sq
; 2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35194602
12.
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies.
EBioMedicine
; 77: 103902, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228013
13.
Solar inactivated Salmonella Typhimurium induces an immune response in BALB/c mice.
Heliyon
; 7(1): e05903, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33553721
14.
Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice.
Sci Rep
; 11(1): 10792, 2021 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031479
15.
Respiratory and Intramuscular Immunization With ChAdOx2-NPM1-NA Induces Distinct Immune Responses in H1N1pdm09 Pre-Exposed Pigs.
Front Immunol
; 12: 763912, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34804053
16.
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice.
Nat Commun
; 12(1): 2893, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001897
17.
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine.
ACS Cent Sci
; 7(4): 594-602, 2021 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34056089
18.
MAIT cell activation augments adenovirus vector vaccine immunogenicity.
Science
; 371(6528): 521-526, 2021 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33510029
19.
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine.
bioRxiv
; 2021 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33501433
20.
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models.
Commun Biol
; 4(1): 915, 2021 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312487